Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Angiotensin AT2Receptor: From a Binding Site to a Novel Therapeutic Target
U. Muscha Steckelings, Robert E. Widdop, Edward D. Sturrock, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 4, pp. 1051-1135
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Alternative Renin-Angiotensin System
Michael Bäder, U. Muscha Steckelings, Natália Alenina, et al.
Hypertension (2024) Vol. 81, Iss. 5, pp. 964-976
Closed Access | Times Cited: 17
Arterial Hypertension in Women: State of the Art and Knowledge Gaps
Niamh Chapman, Siew Mooi Ching, А. О. Конради, et al.
Hypertension (2023) Vol. 80, Iss. 6, pp. 1140-1149
Closed Access | Times Cited: 35
The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies
Bahareh Hassani, Zeinab Attar, Negar Firouzabadi
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 23
Unraveling the crosstalk between renin‐angiotensin system receptors
Mariela M. Gironacci, Ezequiel Bruna‐Haupt
Acta Physiologica (2024) Vol. 240, Iss. 5
Closed Access | Times Cited: 9
Phosphoproteomics for studying signaling pathways evoked by hormones of the renin‐angiotensin system: A source of untapped potential
Igor Maciel Souza‐Silva, Victor Corasolla Carregari, U. Muscha Steckelings, et al.
Acta Physiologica (2025) Vol. 241, Iss. 2
Open Access | Times Cited: 1
The Renin Angiotensin System as a Therapeutic Target in Traumatic Brain Injury
Sonia Villapol, Zachary C. Janatpour, Kwame Ofori Affram, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 6, pp. 1565-1591
Open Access | Times Cited: 20
Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment
Mark C. Chappell
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1320-1337
Open Access | Times Cited: 18
Renin in critically ill patients
Yuki Kotani, Mark C. Chappell, Giovanni Landoni, et al.
Annals of Intensive Care (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
The AT1/AT2 Receptor Equilibrium Is a Cornerstone of the Regulation of the Renin Angiotensin System beyond the Cardiovascular System
Mélissa Colin, Céline Delaitre, Sébastien Foulquier, et al.
Molecules (2023) Vol. 28, Iss. 14, pp. 5481-5481
Open Access | Times Cited: 14
Dysfunction of the renin-angiotensin-aldosterone system in human septic shock
Christopher L. Schaich, Daniel E. Leisman, Marcia B. Goldberg, et al.
Peptides (2024) Vol. 176, pp. 171201-171201
Closed Access | Times Cited: 5
GPCR dimerization: Drug discovery aspects and targets in renin‐angiotensin systems
Tahmid Faisal, Tahir Hussain
FASEB BioAdvances (2025)
Open Access
Angiotensin AT2 receptors reduce inflammation and fibrosis in cardiovascular remodeling
Elena Kaschina, Dilyara Lauer, Christoph Lange, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116062-116062
Open Access | Times Cited: 4
RGS proteins and cardiovascular Angiotensin II Signaling: Novel opportunities for therapeutic targeting
Anastasios Lymperopoulos, Jordana I. Borges, Renee A. Stoicovy
Biochemical Pharmacology (2023) Vol. 218, pp. 115904-115904
Open Access | Times Cited: 10
Utilizing venous occlusion plethysmography to assess vascular effects: A study with buloxibutid, an angiotensin II type 2 receptor agonist
Erik Rein‐Hedin, Folke Sjöberg, Cecilia Ganslandt, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 2
Open Access | Times Cited: 3
An Egg White-Derived Peptide Enhances Systemic Insulin Sensitivity and Modulates Markers of Non-Alcoholic Fatty Liver Disease in Obese, Insulin Resistant Mice
Stepheny C. de Campos Zani, Ren Wang, Hellen Veida-Silva, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 174-174
Open Access | Times Cited: 8
Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in Rats
Göran Tornling, Rohit Batta, Dan Salvail, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7478-7478
Open Access | Times Cited: 8
Recent Advances in Understanding the Molecular Pathophysiology of Angiotensin II Receptors: Lessons From Cell-Selective Receptor Deletion in Mice
Satoru Eguchi, Matthew A. Sparks, Hisashi Sawada, et al.
Canadian Journal of Cardiology (2023) Vol. 39, Iss. 12, pp. 1795-1807
Closed Access | Times Cited: 8
Insights Into the Role of Angiotensin-II AT 1 Receptor-Dependent β-Arrestin Signaling in Cardiovascular Disease
Natalia M. Mathieu, Pablo Nakagawa, Justin L. Grobe, et al.
Hypertension (2023) Vol. 81, Iss. 1, pp. 6-16
Open Access | Times Cited: 7
Angiotensin II type 2 receptor activation preserves megalin in the kidney and prevents proteinuria in high salt diet fed rats
Kalyani Kulkarni, Sanket Patel, Riyasat Ali, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Computational and Enzymatic Studies of Sartans in SARS-CoV-2 Spike RBD-ACE2 Binding: The Role of Tetrazole and Perspectives as Antihypertensive and COVID-19 Therapeutics
Konstantinos Kelaidonis, Irene Ligielli, Spiros Letsios, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8454-8454
Open Access | Times Cited: 6
Sequence-directed concentration of G protein-coupled receptors in COPII vesicles
Xin Xu, Nevin A. Lambert, Guangyu Wu
iScience (2023) Vol. 26, Iss. 10, pp. 107969-107969
Open Access | Times Cited: 6
Catch your breath: The protective role of the angiotensin AT2 receptor for the treatment of idiopathic pulmonary fibrosis
Olivia N. Young, Jane E. Bourke, Robert E. Widdop
Biochemical Pharmacology (2023) Vol. 217, pp. 115839-115839
Open Access | Times Cited: 6
Functional assay for assessment of agonistic or antagonistic activity of angiotensin AT2 receptor ligands reveals that EMA401 and PD123319 have agonistic properties
A. Augusto Peluso, Igor Maciel Souza‐Silva, Daniel C. Villela, et al.
Biochemical Pharmacology (2023) Vol. 216, pp. 115793-115793
Open Access | Times Cited: 5
Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF)
Katyayini Aribindi, Gabrielle Y. Liu, Timothy E. Albertson
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 9, pp. 817-835
Closed Access | Times Cited: 1
The angiotensin AT2-receptor agonist compound 21 is an antagonist for the thromboxane TP-receptor – Implications for preclinical studies and future clinical use
Maise H. Fredgart, Thomas Leurgans, Martin Stenelo, et al.
Peptides (2023) Vol. 164, pp. 170990-170990
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top